KUMULUS VAPE (ALVAP.PA) Fundamental Analysis & Valuation

EPA:ALVAP • FR0013419876

Current stock price

3.34 EUR
-0.01 (-0.3%)
Last:

This ALVAP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ALVAP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALVAP was profitable.
  • In the past year ALVAP has reported a negative cash flow from operations.
  • Each year in the past 5 years ALVAP has been profitable.
  • ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • With an excellent Return On Assets value of 9.80%, ALVAP belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 16.02%, ALVAP is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • ALVAP has a better Return On Invested Capital (12.74%) than 81.48% of its industry peers.
  • ALVAP had an Average Return On Invested Capital over the past 3 years of 13.64%. This is above the industry average of 9.51%.
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROIC 12.74%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • ALVAP has a Profit Margin of 4.35%. This is in the better half of the industry: ALVAP outperforms 74.07% of its industry peers.
  • ALVAP's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALVAP (5.89%) is better than 74.07% of its industry peers.
  • ALVAP's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ALVAP (23.53%) is worse than 72.22% of its industry peers.
  • In the last couple of years the Gross Margin of ALVAP has remained more or less at the same level.
Industry RankSector Rank
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ALVAP.PA Health Analysis

2.1 Basic Checks

  • ALVAP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • ALVAP has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALVAP has more shares outstanding
  • Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 4.42 indicates that ALVAP is not in any danger for bankruptcy at the moment.
  • ALVAP has a Altman-Z score of 4.42. This is amongst the best in the industry. ALVAP outperforms 87.04% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that ALVAP is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.21, ALVAP belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACC1.91
WACC6.66%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.30, ALVAP belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
  • ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.76, ALVAP belongs to the top of the industry, outperforming 90.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALVAP.PA Growth Analysis

3.1 Past

  • ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.52%.
  • ALVAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 97.48% yearly.
  • ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.
  • The Revenue has been growing by 41.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

  • ALVAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.70% yearly.
  • The Revenue is expected to decrease by -0.55% on average over the next years.
EPS Next Y-35.76%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.55%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. ALVAP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALVAP is valuated cheaply with a Price/Earnings ratio of 4.12.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 98.15% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ALVAP to the average of the S&P500 Index (24.75), we can say ALVAP is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 6.12, the valuation of ALVAP can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALVAP is valued cheaply inside the industry as 87.04% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. ALVAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.12
Fwd PE 6.12
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 92.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.08
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • ALVAP has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as ALVAP's earnings are expected to decrease with -2.70% in the coming years.
PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ALVAP.PA Dividend Analysis

5.1 Amount

  • ALVAP has a Yearly Dividend Yield of 5.07%, which is a nice return.
  • The stock price of ALVAP dropped by -23.04% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • ALVAP's Dividend Yield is rather good when compared to the industry average which is at 1.36. ALVAP pays more dividend than 92.59% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALVAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.07%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • 17.40% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.4%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVAP.PA Fundamentals: All Metrics, Ratios and Statistics

KUMULUS VAPE

EPA:ALVAP (3/27/2026, 7:00:00 PM)

3.34

-0.01 (-0.3%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners37.47%
Ins Owner ChangeN/A
Market Cap10.12M
Revenue(TTM)60.68M
Net Income(TTM)2.64M
Analysts86.67
Price Target7.04 (110.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.07%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.85%
EPS NY rev (3m)-1.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.12
Fwd PE 6.12
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.76
EV/EBITDA 2.08
EPS(TTM)0.81
EY24.25%
EPS(NY)0.55
Fwd EY16.34%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS20.03
BVpS5.44
TBVpS4.42
PEG (NY)N/A
PEG (5Y)0.04
Graham Number9.96
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROCE 17.82%
ROIC 12.74%
ROICexc 17.68%
ROICexgc 22.48%
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.42
F-Score3
WACC6.66%
ROIC/WACC1.91
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-35.76%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.55%
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year-5.88%
EBIT Next 3Y2.86%
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA Fundamental Analysis FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.


What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for KUMULUS VAPE?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

The Price/Earnings (PE) ratio for KUMULUS VAPE (ALVAP.PA) is 4.12 and the Price/Book (PB) ratio is 0.61.


Can you provide the financial health for ALVAP stock?

The financial health rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10.